Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMB and Vitamin D with Exercise in Older Adults
NCT02043171Phase 1Completed
- Sponsor
- Metabolic Technologies
- Start
- Aug 2014
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Sarcopenia (4 arms), sponsored by Metabolic Technologies. Primary endpoint: Muscular strength at 12 months. Started Aug 2014; status: completed.
02
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT02043171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043171.